36 results
8-K
EX-99.1
XOMA
XOMA Corp
8 Mar 24
XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value
7:39am
), resulting in XOMA’s receipt of a $5 million milestone payment from Viracta
Tovorafenib data presented at the Society of Neuro-Oncology Annual Meeting
8-K
EX-99.1
XOMA
XOMA Corp
5 May 22
XOMA Reports First Quarter 2022 Financial Results and Highlights Recent Operational Events
7:45am
at Pediatric Endocrine Society Annual Meeting, which took place on May 12,3 and its $130 million registered direct offering and private placement4. We
8-K
EX-99.1
XOMA
XOMA Corp
11 Aug 20
Regulation FD Disclosure
6:05am
, Mexico, and Brazil ▪ Takeda ▪ Received $15.8M from partners during 2019 ‒ TAK-079 & TAK-169 Data presentations at American Society of Hematology … Society of Hematology (ASH) Annual ▪ Completed $22M Rights Offering; backstopped by BVF Meeting 2019 Partners ▪ Ology Bioservices ▪ Added Natasha
8-K
EX-99.1
XOMA
XOMA Corp
13 Jan 20
Regulation FD Disclosure
6:09am
trial required Rolling BLA initiated Dec ’19 Takeda TAK-079 & TAK-169 Data presentations at American Society of Hematology (ASH) Annual Meeting 2019
424B3
lt71t3o5v7s09mat
19 Dec 11
Prospectus supplement
12:00am